Skip to main content
. 2019 Jul 20;17(7):425. doi: 10.3390/md17070425

Table 2.

Clinical signs of toxicity in mice and extrapolation in humans.

Clinical Signs of Toxicity in Mice. Anatomical or Physiological Support Possible Outcome in Humans
Loss of motor activity Neuromuscular junction impairment (skeletal muscles) Myasthenic syndrome analogous with the disease myasthenia gravis
Flaccid paralysis caused by curare
Respiratory depression/arrest Neuromuscular junction impairment/block (diaphragm) Respiratory impairment/arrest in myasthenia and myasthenic crisis
Seizure Central damage via nAChR inhibition Seizure crisis (impaired GABA release
or hereditary mutations)
Leg extension Spinal interneuron impairment
Central impairment
Pyramidal syndrome
Babinski sign
Reversibility if no death occurs
or after prostigmine injection
Removal of the post-synaptic neuromuscular block Fluctuation in the degree of myasthenic syndrome
or temporary removal of the block with prostigmine
Removal of the curare action
Exophthalmos Increased intraocular pressure Action of suxamethonium
Action of lupin
Hypersalivation, vomiting, diarrhea, bradycardia, bronchoconstriction, miosis Inhibition of neuronal communication at ganglia synapses Autonomous agents acting on the sympathetic nervous system (side effects). Nicotinic syndrome
Tachycardia, blood hypertension, mydriasis Inhibition of neuronal communication at ganglia synapses Autonomous agents acting on the parasympathetic nervous system (side effects). Muscarinic syndrome